Skip to main content
. 2010 Sep;100(9):1769–1776. doi: 10.2105/AJPH.2009.160184

TABLE 3.

Adjusted Proportions (Predicted Marginals) Meeting Program Standards for Diagnostic and Treatment Initiation Intervals: National Breast and Cervical Cancer Early Detection Program, 1996–2005

Diagnostic Interval
Treatment Interval
Total Interval
1996–2000
2001–2005
1996–2000
2001–2005
1996–2000
2001–2005
Characteristic Predicted Marginala (95% CI) P Predicted Marginala (95% CI) P Predicted Marginala (95% CI) P Predicted Marginala (95% CI) P Predicted Marginalb (95% CI) P Predicted Marginalb (95% CI) P
Mammogram resultc/CBE resultd <.001 <.001 <.001 .027 <.001 <.001
    Abnormal/normal 82 (81, 82) 83 (82, 83) 93 (92, 94) 93 (93, 94) 89 (87, 90) 90 (89, 91)
    Abnormal/abnormal 82 (82, 83) 84 (83, 84) 95 (94, 96) 94 (94, 95) 94 (94, 95) 96 (95, 96)
    Abnormal/not done 81 (80, 81) 83 (82, 83) 91 (89, 93) 92 (91, 94) 87 (85, 90) 91 (89, 92)
    Normal/abnormal 77 (76, 78) 82 (82, 82) 95 (92, 97) 92 (89, 95) 84 (80, 88) 86 (83, 89)
    Not done/abnormal 81 (80, 82) 80 (79, 81) 90 (87, 92) 94 (92, 95) 91 (89, 94) 94 (93, 95)
Age, years .126 .629 .118 .113 .368 .340
    40–49 81 (81, 81) 83 (82, 83) 94 (93, 95) 93 (92, 94) 91 (90, 92) 92 (92, 93)
    50–64 81 (80, 81) 83 (82, 83) 93 (92, 94) 94 (94, 94) 91 (90, 92) 93 (93, 94)
    ≥ 65 80 (79, 81) 82 (81, 83) 95 (93, 96) 93 (90, 95) 92 (90, 94) 92 (90, 95)
Race/ethnicity <.001 <.001 <.001 <.001 <.001 <.001
    White 84 (83, 84) 88 (88, 88) 95 (94, 95) 94 (94, 95) 93 (92, 94) 95 (94, 95)
    Black 76 (76, 77) 80 (79, 80) 91 (90, 93) 91 (90, 92) 87 (86, 89) 89 (88, 90)
    Asian 79 (78, 80) 76 (75, 77) 95 (93, 98) 95 (93, 97) 88 (84, 92) 92 (90, 94)
    AIAN 76 (75, 77) 80 (79, 81) 90 (86, 94) 93 (91, 96) 87 (83, 91) 90 (87, 93)
    Hispanic 78 (77, 78) 77 (77, 78) 91 (89, 93) 94 (93, 95) 87 (85, 89) 92 (91, 93)
    Unknown 79 (78, 81) 79 (78, 80) 96 (94, 99) 96 (94, 98) 89 (84, 93) 92 (90, 95)
Residence <.001 <.001 .003 .016 <.001 <.001
    Urban 83 (82, 83) 85 (85, 86) 95 (94, 96) 95 (94, 95) 93 (91, 94) 94 (93, 95)
    Metropolitan 80 (80, 80) 82 (82, 82) 93 (92, 94) 93 (93, 94) 90 (89, 91) 92 (92, 93)
    Rural 82 (81, 83) 85 (85, 86) 95 (93, 98) 95 (94, 97) 95 (92, 97) 95 (93, 96)
Breast symptoms <.001 <.001 <.359 .051 .235 <.001
    Yes 81 (81, 82) 85 (84, 85) 93 (92, 94) 94 (94, 95) 92 (91, 93) 94 (94, 95)
    No 80 (80, 81) 82 (82, 82) 94 (93, 95) 93 (92, 94) 90 (89, 91) 92 (91, 92)
    Unknown 81 (81, 82) 84 (84, 85) 93 (92, 95) 94 (92, 95) 91 (88, 93) 94 (93, 96)
Cancer Diagnosed 0.22 <.001
    Yes 82 (81, 83) 85 (84, 85) NA NA NA NA
    No 81 (80, 81) 82 (82, 83) NA NA NA NA

Notes. CI = confidence interval; CBE = clinical breast examination; AIAN = American Indian/Alaska Native.

a

Percentage ≤ 60 days).

b

Percentage ≤120 days).

c

Abnormal mammography includes suspicious abnormality, highly suggestive for malignancy, or assessment incomplete.

d

Abnormal CBE is suspicious for cancer.